ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005

Professional Societies: ASCO Develops Cancer Genetics Curriculum

December 18, 1998

Wiernik Loses Post At Einstein Following Unauthorized Trials

November 5, 1993

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012

Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia

September 27, 2013